TCM
TCG Crossover Management Portfolio holdings
AUM
$876M
This Quarter Return
+83.13%
1 Year Return
+23.66%
3 Year Return
+996.72%
5 Year Return
–
10 Year Return
–
AUM
$567M
AUM Growth
+$567M
(+70%)
Cap. Flow
+$177M
Cap. Flow
% of AUM
31.24%
Top 10 Holdings %
Top 10 Hldgs %
79.55%
Holding
26
New
5
Increased
7
Reduced
4
Closed
5
Top Buys
| 1 |
Madrigal Pharmaceuticals
MDGL
|
$74.9M |
| 2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$27M |
| 3 |
Ventyx Biosciences
VTYX
|
$25.8M |
| 4 |
KalVista Pharmaceuticals
KALV
|
$23M |
| 5 |
VECT
VectivBio Holding AG Ordinary Shares
VECT
|
$20.2M |
Top Sells
| 1 |
ALLK
Allakos
ALLK
|
$10.1M |
| 2 |
AKUS
Akouos, Inc. Common Stock
AKUS
|
$9.13M |
| 3 |
Viridian Therapeutics
VRDN
|
$5.27M |
| 4 |
Tango Therapeutics
TNGX
|
$4.24M |
| 5 |
Dianthus Therapeutics
DNTH
|
$2.99M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ISEE
1
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $110M | 19.43% | 5,141,118 +1,263,215 | +33% | +$27M |
|
|
2
Madrigal Pharmaceuticals
MDGL
$9.76B
| $83.6M | 14.76% | 288,054 +258,054 | +860% | +$74.9M |
|
3
Cogent Biosciences
COGT
$1.69B
| $42M | 7.41% | 3,631,042 +150,000 | +4% | +$1.73M |
|
|
CBAY
4
DELISTED
Cymabay Therapeutics
CBAY
| $37M | 6.53% | 5,905,400 | – | – |
|
5
Geron
GERN
$893M
| $36.8M | 6.49% | 15,187,073 +3,071,147 | +25% | +$7.43M |
|
|
SLN
6
Silence Therapeutics
SLN
$227M
| $32.1M | 5.67% | 2,104,875 | – | – |
|
|
JBIO
7
Jade Biosciences, Inc. Common Stock
JBIO
$258M
| $31.7M | 5.59% | 1,081,274 +121,702 | +13% | +$3.57M |
|
|
8
Viridian Therapeutics
VRDN
$1.5B
| $28.7M | 5.07% | 983,610 -180,390 | -15% | -$5.27M |
|
|
9
Ventyx Biosciences
VTYX
$171M
| $25.8M | 4.56% | +787,231 | New | +$25.8M |
|
|
10
KalVista Pharmaceuticals
KALV
$678M
| $23M | 4.05% | +3,395,495 | New | +$23M |
|
|
VECT
11
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
| $20.2M | 3.57% | +2,333,300 | New | +$20.2M |
|
12
Aclaris Therapeutics
ACRS
$209M
| $18M | 3.18% | 1,144,939 | – | – |
|
13
Kura Oncology
KURA
$686M
| $17.7M | 3.12% | 1,423,642 +75,000 | +6% | +$931K |
|
14
Immunovant
IMVT
$2.56B
| $15.2M | 2.68% | +854,853 | New | +$15.2M |
|
15
Tyra Biosciences
TYRA
$675M
| $15.1M | 2.67% | 1,989,103 +1,043,396 | +110% | +$7.93M |
|
16
MoonLake Immunotherapeutics
MLTX
$3.54B
| $10.5M | 1.85% | 1,000,000 | – | – |
|
17
Entrada Therapeutics
TRDA
$208M
| $7.91M | 1.4% | 584,955 -57,234 | -9% | -$774K |
|
18
Merus
MRUS
$4.98B
| $4.64M | 0.82% | 300,000 | – | – |
|
19
Cabaletta Bio
CABA
$133M
| $4.5M | 0.79% | +486,795 | New | +$4.5M |
|
|
ALPN
20
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $1.86M | 0.33% | 253,069 -1,500 | -0.6% | -$11K |
|
|
ELEV
21
DELISTED
Elevation Oncology
ELEV
| $274K | 0.05% | 288,390 -266,610 | -48% | -$253K |
|
|
ALLK
22
DELISTED
Allakos
ALLK
| – | – | -1,643,500 | Closed | -$10.1M |
|
|
23
Dianthus Therapeutics
DNTH
$759M
| – | – | -2,124,122 | Closed | -$2.99M |
|
|
24
Tango Therapeutics
TNGX
$747M
| – | – | -1,172,250 | Closed | -$4.24M |
|
25
Zai Lab
ZLAB
$3.68B
| – | – | -72,777 | Closed | -$2.49M |
|